The Breast
Volume 19, Issue 2 , Pages 97-104 , April 2010

Breast cancer in women under 40years of age: A series of 57 cases from Northern Ireland

  • B. McAree

      Affiliations

    • Department of General Surgery, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
    • ,
  • M.E. O'Donnell

      Affiliations

    • Department of General Surgery, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
    • School of Life and Health Sciences, University of Ulster, UK
    • Corresponding Author InformationCorresponding author at: 11 Wicket Lane, Saintfield, Ballynahinch, County Down, BT24 7FJ, Northern Ireland, UK. Tel.: +44 2897 519511 +44 7793 585686 (mobile).
    • ,
  • A. Spence

      Affiliations

    • Department of General Surgery, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
    • ,
  • T.F. Lioe

      Affiliations

    • Department of Pathology, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
    • ,
  • D.T. McManus

      Affiliations

    • Department of Pathology, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
    • ,
  • R.A.J. Spence

      Affiliations

    • Department of General Surgery, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
    • School of Life and Health Sciences, University of Ulster, UK
    • Department of Surgery, Queens University Belfast, Belfast, UK

Received 14 July 2009 ,Revised 2 December 2009 ,Accepted 4 December 2009.

References 

  1. NHS breast screening programmes . Breast cancer. http://www.cancerscreening.nhs.uk/breastscreen/breastcancer.html#incidenceparagraph 1.2 (last accessed 05/06/2009)
  2. Fitzpatrick D, Gavin A, Middleton R, Catney D. Cancer in Northern Ireland 1993–2001. Belfast: Northern Ireland Cancer Registry; 2004;a comprehensive report
  3. Castiglione M, Aebi S. The enigma of young age. Ann Oncol. 2006;17(10):1475–1477
  4. Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, et al. Relationship of patient age to pathological features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994;12(5):888–894
  5. Dubsky PC, Gnant MF, Taucher S, Roka S, Kandioler D, Pichler-Gebhard B, et al. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer. 2002;3(1):65–72
  6. Aebi S, De Ridder M, Vlastos G, Vinh-Hung V, Storme G. Young age is a poor prognostic factor in women with stage I breast cancer. Eur J Cancer Suppl. 2006;4(2):121
  7. Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin P, et al. Age as a prognostic factor in breast cancer: relationship to pathological and biologic features. Int J Cancer. 2006;62(2):138–144
  8. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;77(1):97–103
  9. NICE clinical guideline 41 . ; Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care; paragraph 1.4.5 Referral to tertiary care. http://www.nice.org.uk(accessed 01/05/2009)
  10. McCavert M, O'Donnell ME, Aroori S, Badger SA, Sharif MA, Crothers JG, et al. The role of ultrasound as an adjunct to mammography in the assessment of breast tumours. Int J Clin Practice. 2009;63(11):1589–1594
  11. Non-operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening Publication No 50. National Health Service Breast Screening Programme NHSBSP 2001.
  12. NHSBSP guidelines for pathology reporting in breast disease (a joint document incorporating the 3rd edition of the NHS Breast Screening Programme's guidelines for pathology reporting in breast cancer screening and the 2nd edition of The Royal College of Pathologists minimum dataset for breast cancer histopathology). NHSBSP publication No.58. London, England: National Health Service Breast Screening Programme, 2005.
  13. Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992;22(3):207–219
  14. Improving outcomes in breast cancer - 28 . Urgent referral to breast clinics; page 20; paragraph 2. http://www.nice.org.uk/nicemedia/pdf/improving_outcomes_breastcancer_manual.pdfAugust 2002;(accessed 05/06/2009)
  15. Foxcroft LM, Evans EB, Porter AJ. The diagnosis of breast cancer in women younger than 40. Breast. 2004;13(4):297–306
  16. Pathology reporting of breast disease. A joint document incorporating the third edition of the NHS Breast Screening Programme's guidelines for pathology reporting in breast cancer screening and the second edition of The Royal College of Pathologists’ minimum dataset for breast cancer histopathology. NHSBSP publication no. 58 January 2005. Published by the NHS Cancer Screening Programmes jointly with The Royal College of Pathologists.
  17. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–1675
  18. Irvin WJ, Carey LA. What is triple-negative breast cancer?. Eur J Cancer. 2008;44(18):2799–2805
  19. Cancer research UK . UK breast cancer incidence statistics; page 1; table 1.1. http://www.info.cancerresearchuk.org/cancerstats/types/breast/incidence/(accessed 05/06/2009)
  20. Winchester DP. Breast cancer in young women. Surg Clin North Am. 1996;76(2):279–287
  21. Northern Ireland Cancer Registry . Chapter 13 Cancer of the female breast. http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/Breast/ICD-9 174 (accessed 05/06/2009)
  22. Northern Ireland Cancer Registry . a comprehensive report. Cancer in Northern Ireland. Queen's University of Belfast; 1993–2001;http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/Breast/(Comprehensive) (accessed 05/06/2009)
  23. NHS Cancer Screening Programmes . NHS breast screening programme; paragraph 2: What does the NHS breast screening programme do? page 1; paragraph 2. http://www.cancerscreening.nhs.uk/breastscreen/(accessed 04/06/2009)
  24. Agnese DM, Yusuf F, Wilson JL, Shapiro CL, Lehman A, Burak WE. Trends in breast cancer presentation and care according to age in a single institution. Am J Surg. 2004;188(4):437–439
  25. Turchetti D, Cortesi L, Federico M, Bertoni C, Mangone L, Ferrari S, et al. BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. Eur J Cancer. 2000;36(16):2083–2089
  26. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999;91(11):943–949
  27. Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, et al. BRCA-associated breast cancer in young women. J Clin Oncol. 1998;16(5):1642–1649
  28. Radford DM, Zehnbauer BA. Inherited breast cancer. Surg Clin North Am. 1996;76(2):205–220
  29. Fernandopulle SM, Cher-Siangang P, Tan PH. Breast carcinoma in women 35years and younger: a pathological study. Pathology. 2006;38(3):219–222
  30. Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, et al. Very young women (<35years) with operable breast cancer: features of disease at presentation. Ann Oncol. 2002;13(2):273–279
  31. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324–3330
  32. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Breast carcinoma in women 35years of age or younger. Ann Surg. 1984;199(2):133–142
  33. Albain KS, Allred DC, Clark GM. Breast cancer outcome and predictors of outcome: are there age differentials?. J Natl Cancer Inst Monogr. 1994;16:35–42
  34. Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin PM, et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer. 1995;62(2):138–144
  35. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer. 2003;39(7):932–944
  36. Thike AA, Chng MJ, Fook-Chong S, Tan PH. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology. 2001;33(1):21–25
  37. Northern Ireland Department of Health, Social Services and Public Safety . news release. Herceptin. http://www.dhsspsni.gov.uk/publications/2005/Herceptin2005;(accessed 05/06/2009)
  38. Van Nes JG, van de Velde CJ. The preferred treatment for young women with breast cancer – mastectomy versus breast conservation. Breast. 2006;15(Suppl.2):S3–10
  39. Zhou P, Gautam S, Recht A. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2007;101(1):51–57
  40. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol. 2006;13(3):333–339
  41. Jardines L, Fowble B, Schultz D, Mackie J, Buzby G, Torosian M, et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery. 1995;118:803–809
  42. Taghian A, Mohiuddin M, Jagsi R, Golberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005;241:629–639
  43. van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Pre-operative chemotherapy in primary operable breast cancer: results from the European Organisation for Research and Treatment of Cancer Trial 10902. J Clin Oncol. 2001;19:4224–4237
  44. Ingram DM, McEvoy SP, Byrne MJ, Fritschi L, Joseph DJ, Jamrozik K. Surgical caseload and outcomes for women with invasive breast cancer treated in Western Australia. Breast. 2005;14(1):11–17
  45. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19(8):2263–2271
  46. Goldstein NS, Vicini FA, Kestin LL, Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer. 2000;88(11):2553–2560

PII: S0960-9776(09)00174-X

doi: 10.1016/j.breast.2009.12.002

The Breast
Volume 19, Issue 2 , Pages 97-104 , April 2010

Article Tools

* Image Usage & Resolution